Is a Watchman a Pacemaker? Key Differences Explained

A Watchman device is not a pacemaker. The two are entirely different cardiac implants that treat different conditions, sit in different parts of the heart, and work by different mechanisms. A Watchman is a small plug placed inside the left atrial appendage to prevent blood clots from escaping and causing a stroke, while a pacemaker is an electronic device that sends electrical pulses to the heart muscle to keep it beating at a steady rhythm. The confusion is understandable because both involve procedures performed by cardiologists, both end up inside or near the heart, and both are sometimes discussed in the same appointment. But they solve completely separate problems.

What the Watchman Device Actually Does

The Watchman is designed for people with a type of irregular heartbeat called nonvalvular atrial fibrillation. When the heart’s upper chambers quiver instead of contracting smoothly, blood can pool in a small pouch called the left atrial appendage. That pooled blood tends to form clots, and if a clot breaks loose and travels to the brain, the result is a stroke. Traditionally, the solution has been long-term blood-thinning medication. The Watchman offers a mechanical alternative: a tiny, parachute-shaped device made of a nickel-titanium frame covered in fabric, delivered through a catheter threaded up from a vein in the leg and positioned to seal off the left atrial appendage permanently.¹ Once the tissue of the heart grows over the device, blood can no longer collect in that pouch, and the stroke risk drops without the need for lifelong anticoagulants.

The Watchman is specifically intended for patients who have difficulty tolerating blood thinners, whether because of a high bleeding risk, a history of dangerous bleeding events, or other medical reasons that make long-term anticoagulation impractical.² It does not regulate the heart’s rhythm in any way. It does not speed up a slow heartbeat, slow down a fast one, or deliver any electrical signals. Its job is purely structural: block a pouch where clots form.

What a Pacemaker Does

A pacemaker is an electronic pulse generator. It monitors the heart’s electrical activity and, when the heartbeat drops too slow or skips in a dangerous pattern, delivers a small electrical impulse to prompt the heart muscle to contract. The device treats symptomatic bradycardia, which is a heartbeat that is too slow to supply the body with enough blood, causing dizziness, fainting, fatigue, or shortness of breath. Pacemakers remain the only effective treatment for this condition.³

Traditional pacemakers consist of a small battery-powered generator implanted under the skin near the collarbone and one or more thin wires (leads) threaded through a vein into the heart’s chambers. Newer “leadless” pacemakers, like the Micra, are tiny capsules placed directly inside the heart via a catheter, eliminating the chest incision and the wires entirely. Regardless of form factor, every pacemaker’s core job is the same: sense the heart’s rhythm and deliver electricity when needed.

Where Each Device Sits in the Heart

The physical locations of these two devices inside the heart underscore how different they are. The Watchman is placed in the left atrial appendage, a small ear-shaped pouch protruding from the left atrium, which is the upper-left chamber of the heart. The device lodges there like a cork in a bottle, sealing the opening so blood cannot pool and clot inside that pouch.

A traditional pacemaker’s leads typically sit in the right side of the heart, with the tip anchored in the right ventricle, the right atrium, or both. A leadless pacemaker is implanted directly into the right ventricle. So in most cases, the Watchman lives on the left side of the heart and the pacemaker lives on the right. They occupy different chambers, serve different purposes, and do not interact with each other at all.

Different Conditions, Different Patients

The overlap in the patient populations is what causes much of the confusion. Atrial fibrillation is extremely common in older adults, and so is age-related slowing of the heart’s electrical conduction system. A person with atrial fibrillation might also develop periods of abnormally slow heart rate, a combination sometimes called tachy-brady syndrome. That person could genuinely need both a Watchman and a pacemaker, but the two devices would be treating two separate problems: the Watchman handles the stroke risk from the fibrillation, and the pacemaker handles the dangerously slow heart rate.

It is worth noting that not every person with atrial fibrillation is a candidate for a Watchman. The device is indicated for nonvalvular atrial fibrillation specifically, and it is aimed at people for whom long-term oral anticoagulation is problematic. Many patients with atrial fibrillation do fine on blood thinners and never need a Watchman at all. Likewise, not every person with a slow heart rate needs a pacemaker. Only when symptoms are significant and tied to the slow rhythm does implantation become necessary.

Can You Have Both at the Same Time?

Yes. Some patients receive both a Watchman and a pacemaker, and in at least one documented case, both devices were implanted in the same procedure. A 73-year-old woman with persistent atrial fibrillation and tachy-brady syndrome who could not tolerate oral anticoagulants received both a Watchman and a leadless pacemaker (Micra) through the same vein in the leg during a single sitting. She tolerated both procedures without complications, and both devices were functioning well at the one-month follow-up.⁴

This case illustrates the point clearly: these are two independent devices addressing two independent problems. Neither one replaces the other. Having a pacemaker does not protect against stroke from atrial fibrillation, and having a Watchman does not fix a slow heartbeat. Patients who need both will get both, sometimes on different occasions and sometimes, as in this case, all at once.

How the Procedures Differ

Both devices are implanted through catheter-based procedures, which may be another reason they get confused. But the details of the procedures diverge considerably.

A traditional pacemaker implantation involves a small incision near the collarbone, creation of a pocket under the skin for the generator, and threading of one or more leads through a vein into the heart. It is typically performed under local anesthesia with sedation, lasts about an hour, and patients often go home the same day or the next morning. A leadless pacemaker implantation skips the chest incision entirely; the tiny device is delivered through a catheter inserted in the femoral vein in the groin, guided into the right ventricle, and anchored directly to the heart wall.

Watchman implantation also uses the femoral vein route, but the catheter must cross from the right side of the heart to the left side through the atrial septum (the wall between the two upper chambers) via a puncture called a transseptal access. The device is then guided into the left atrial appendage and deployed. This procedure is typically performed under either conscious sedation or general anesthesia, with imaging guidance to confirm proper positioning. The choice of delivery system for the Watchman has evolved over time. Newer steering systems allow the operator to actively control the angle of the catheter tip, potentially making it easier to achieve proper alignment across the wide range of left atrial appendage shapes that exist from patient to patient.²

Risks and Complications

The risk profiles of the two devices are different because the procedures and locations differ. Pacemaker implantation is one of the most commonly performed cardiac procedures in the world, and serious complications are rare, though they can include infection at the generator site, lead displacement, and, very uncommonly, perforation of the heart wall during lead placement. Leadless pacemakers avoid some of these risks (no pocket infection, no lead fracture) but introduce others, such as the possibility of dislodgement from the heart wall.

Watchman complications reflect the unique challenges of working inside the left atrium. The most common serious complication is pericardial effusion, which is a collection of fluid around the heart, occurring at rates that have been reported anywhere from about 0.3% to roughly 5% of procedures. Device embolization, meaning the device migrates from its intended position, occurs in roughly 0.2% to 0.7% of cases. Procedural stroke rates sit at approximately 1% across a range of studies.⁵ Another concern specific to the Watchman is device-related thrombus, where a clot forms on the surface of the device itself before the heart tissue has fully covered it. A large pooled analysis estimated this risk at about 3.8%.⁵

None of these complication types overlap. You would not worry about lead fracture with a Watchman, and you would not worry about device-related thrombus with a pacemaker. The risk conversations your doctor has with you before each procedure will be entirely different.

Life After Implantation

Post-procedure life looks quite different depending on which device you receive. A pacemaker requires periodic follow-up visits, or increasingly remote monitoring, to check battery life, lead function, and programming settings. Modern pacemaker batteries last roughly 8 to 15 years depending on how much pacing the heart requires, and when the battery runs low, the generator is replaced in a minor surgical procedure. The leads can often stay in place for decades. Patients with pacemakers need to be aware of certain electromagnetic interference risks, though modern devices are far more resilient to everyday electronics than older models were.

The Watchman, by contrast, is a one-time implant with no battery and no moving parts. Once the heart tissue grows over the device and follow-up imaging confirms that the left atrial appendage is fully sealed, the patient’s active relationship with the device is essentially over. The main post-procedural obligation is a temporary medication regimen. Patients typically take a short course of blood thinners or antiplatelet drugs in the weeks to months after Watchman implantation to prevent clots from forming on the device before tissue coverage is complete. After that window closes and imaging confirms adequate sealing, many patients are able to stop anticoagulation entirely, which is the whole point of the device for people who cannot tolerate those medications long-term.

Other Cardiac Devices That Add to the Confusion

Part of the reason people conflate the Watchman with a pacemaker is that the landscape of implantable cardiac devices has become remarkably crowded, and unless you work in cardiology, it is hard to keep them straight. Beyond pacemakers and the Watchman, there are implantable cardioverter-defibrillators (ICDs), which look and are implanted much like pacemakers but have the additional ability to deliver a strong shock to reset a dangerously fast heart rhythm. ICDs are used to prevent sudden cardiac death, a separate indication from both the Watchman’s stroke prevention role and the pacemaker’s rhythm-regulation role.³ There are also cardiac resynchronization therapy devices, which coordinate the timing of contractions between the heart’s ventricles in certain heart failure patients. And subcutaneous ICDs, which sit under the skin outside the ribcage rather than inside the heart, add yet another category.

Each of these devices has a distinct medical indication, a distinct mechanism of action, and a distinct risk profile. None of them is interchangeable with any other. When a doctor recommends one of these devices, it is worth understanding which category it falls into and what specific problem it is designed to address, because the post-procedure expectations, follow-up schedules, and lifestyle implications are all different.

Long-Term Cost Considerations

For patients weighing whether a Watchman procedure makes sense financially, especially if they are also considering the ongoing cost of blood-thinning medications, there is evidence that the Watchman becomes cost-effective over time. One economic analysis found that left atrial appendage closure produced slightly more quality-adjusted life years than aspirin alone or the anticoagulant apixaban, and became cost-saving compared to aspirin at around seven years and compared to apixaban at about eight years. Before those breakeven points, the upfront cost of the procedure made it more expensive, but the savings from eliminating ongoing medication costs and reducing stroke-related hospitalizations accumulated over time.⁶

Pacemaker costs follow a different trajectory. The upfront device and implantation costs are significant, but the ongoing costs are relatively modest: periodic check-ups, remote monitoring fees, and eventual generator replacement every decade or so. There is no equivalent medication-elimination benefit because pacemakers do not replace a drug regimen in the way the Watchman replaces anticoagulants. The financial calculus for each device depends on entirely different variables, which is one more way they have nothing in common beyond both being implanted cardiac hardware.

MRI Compatibility and Daily Life

A practical concern many patients share across both devices is whether they can safely undergo MRI scans. Older pacemakers were considered absolute contraindications for MRI because the magnetic field could heat the leads or interfere with the device’s programming. Modern pacemakers are increasingly labeled as MRI-conditional, meaning they can be scanned safely under specific conditions (certain magnet strengths, certain body regions, with the device temporarily reprogrammed beforehand). If you have a pacemaker and need an MRI, your cardiology team will check whether your specific device and leads are MRI-conditional and adjust settings accordingly.

The Watchman, being a passive metal-and-fabric plug with no electronics, does not carry the same electromagnetic interference concerns. Once it is implanted and the tissue has grown over it, it generally does not restrict your ability to get MRI scans or walk through metal detectors at the airport. This is a meaningful quality-of-life difference for people who already have one device and are trying to understand what a second one would mean for their daily routines.

When the Question Really Matters

The stakes of confusing these two devices go beyond trivia. If you have atrial fibrillation and your doctor suggests a Watchman, and you believe it is “like a pacemaker,” you might expect it to control your irregular heartbeat. It will not. You might stop taking your rate-control or rhythm-control medications, thinking the device handles that. It does not. The Watchman addresses only the clot-and-stroke side of atrial fibrillation, not the electrical disturbance itself. Conversely, if you receive a pacemaker for a slow heart rate and assume it also protects you against stroke, you might neglect the blood thinners your doctor prescribes for coexisting atrial fibrillation, leaving yourself dangerously unprotected.

Asking your cardiologist “is this like a pacemaker?” is a perfectly reasonable question, and the answer should be a clear “no, and here is why.” Understanding the distinction is not academic hairsplitting. It directly affects which medications you continue taking, which follow-up appointments you keep, and what symptoms you should watch for after the procedure.